Saturday, March 30, 2024 12:17:12 PM
Wed, Feb 28, 2024
American Rare Earths Limited CEO Donald Swartz joined Steve Darling from Proactive to share significant news regarding the company's recent fundraising efforts. American Rare Earths has successfully secured firm commitments for a placement to raise 13.5 million Australian dollars.
This placement received strong support from both new and existing institutional, professional, and sophisticated investors, both domestically and offshore. The purpose of this capital raise is to further develop environmentally friendly and cost-effective extraction and processing methods.
These methods are crucial to meeting the rapidly increasing demand for resources essential to the clean energy transition and US national security. Swartz emphasized that this funding provides the company with the necessary capital to advance its flagship project, Halleck Creek, towards delivering a secure supply of critical minerals to the North American supply chain.
American Rare Earths remains dedicated to achieving its project development milestones with the support of its shareholders. The funds raised will support various activities related to the development of the Halleck Creek Rare Earths Project in Wyoming.
These activities include mineral resource and extensional drilling, pre-feasibility studies, metallurgical test work and process development, as well as heritage, permitting, and environmental activities.
Overall, this successful capital raise positions American Rare Earths to continue its progress towards becoming a key player in the critical minerals sector, contributing to both environmental sustainability and national security objectives.
Contact Details
Proactive USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
View source version on newsdirect.com: https://newsdirect.com/news/american-rare-earths-helps-advancement-at-halleck-creek-with-13-5-million-dollar-private-placement-524973282
https://finance.yahoo.com/news/american-rare-earths-helps-advancement-122506231.html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM